Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -68.64% is 151% below its 5-year average of -27.34%, near the low end of its 5-year range (-68.64%–19.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.73% below its 12-month average of -58.80%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -68.64%.
RETURN ON INVESTED CAPITAL (ROIC)
-68.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-58.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-44.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.73%
CURRENT VS 3Y AVG
-55.24%
CURRENT VS 5Y AVG
-151.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
-138.45%
vs the sector median at left
Cullinan Therapeutics, Inc.
Market Cap
$1.06B
Return on Invested Capital (ROIC)
-68.64%
TTM Avg
-58.80%
3Y Avg
-44.21%
5Y Avg
-27.34%
Market Cap
$1.06B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
Market Cap
$1.05B
Return on Invested Capital (ROIC)
20.01%
TTM Avg
1.42%
3Y Avg
2.77%
5Y Avg
3.34%
Market Cap
$1.04B
Return on Invested Capital (ROIC)
-53.36%
TTM Avg
-19.72%
3Y Avg
-15.42%
5Y Avg
-34.93%
Market Cap
$1.02B
Return on Invested Capital (ROIC)
-15.15%
TTM Avg
-12.74%
3Y Avg
-16.16%
5Y Avg
-18.46%
Market Cap
$1.01B
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-132.46%
3Y Avg
-76.17%
5Y Avg
-76.17%
Market Cap
$1.12B
Return on Invested Capital (ROIC)
20.18%
TTM Avg
20.20%
3Y Avg
19.35%
5Y Avg
14.75%
Market Cap
$1.12B
Return on Invested Capital (ROIC)
-6.33%
TTM Avg
-3.44%
3Y Avg
-10.34%
5Y Avg
-8.68%
Market Cap
$995.46M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | $1.06B | -68.64% | -58.80% | -44.21% | -27.34% |
| Teladoc Health, Inc. (TDOC)vs › | $1.06B | -7.32% | -21.18% | -91.27% | -61.58% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.05B | 20.01% | 1.42% | 2.77% | 3.34% |
| Immatics N.V. (IMTX)vs › | $1.04B | -53.36% | -19.72% | -15.42% | -34.93% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | -15.15% | -12.74% | -16.16% | -18.46% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.01B | -28.14% | -132.46% | -76.17% | -76.17% |
| IRadimed Corporation (IRMD)vs › | $1.12B | 20.18% | 20.20% | 19.35% | 14.75% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -6.33% | -3.44% | -10.34% | -8.68% |
| Aktis Oncology, Inc. (AKTS)vs › | $995.46M | -16.54% | -24.45% | -23.43% | -23.43% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 5.93% | 9.95% | 11.37% | 9.31% |
ROIC
-68.6%
ROE
-63.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -68.64% |
| 2026-03-31 | -65.34% |
| 2025-12-31 | -58.85% |
| 2025-09-30 | -53.49% |
| 2025-06-30 | -47.68% |
| 2025-03-31 | -37.83% |
| 2024-12-31 | -33.31% |
| 2024-09-30 | -29.78% |
| 2024-06-30 | -27.94% |
| 2024-03-31 | -40.07% |
| 2023-12-31 | -41.90% |
| 2023-09-30 | -37.66% |
| 2023-06-30 | -32.28% |
| 2023-03-31 | 12.84% |
| 2022-12-31 | 19.37% |
| 2022-09-30 | 16.92% |
| 2022-06-30 | 17.86% |
| 2022-03-31 | -24.22% |
| 2021-12-31 | -15.97% |
| 2021-09-30 | -14.09% |
| 2021-06-30 | -12.19% |
| 2021-03-31 | -11.37% |
| 2020-12-31 | -30.11% |
| 2020-09-30 | -16.87% |
| 2020-06-30 | -31.92% |
| 2019-12-31 | -22.74% |
